periorbital aging/wrinkles/hyperpigmentation. Other melanin hyperpigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: participants aged 20 to 65 years presenting with age-related periorbital changes (including dark circles, periorbital wrinkles, decreased skin firmness, and under-eye laxity), who provide informed consent and are able to attend follow-up visits, will be included in the study.
Exclusion criteria
Exclusion criteria: Active inflammation or herpetic infection at the procedure site, collagen vascular diseases, or warts use of corticosteroids, immunosuppressive, anticoagulant, or antiplatelet medications platelet function disorders or thrombocytopenia pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pigmentation (color of the lesion). Timepoint: 1 and 3 months after the treatment. Method of measurement: Skin analysis using the VisioFace system/Patient satisfaction (Patient Global Assessment Score/Physician satisfaction (Physician Global Assessment Score.;Wrinkle. Timepoint: 1 and 3 months after the treatment. Method of measurement: Skin analysis using the VisioFace system/Patient satisfaction (Patient Global Assessment Score/Physician satisfaction (Physician Global Assessment Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications. Timepoint: 1 and 3 months after the treatment. Method of measurement: Using a checklist containing treatment complications including pain, erythema and edema. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences